Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 186.76 | (64.56) | (11.33)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-26 | 260.39 | (34.20) | (6.33)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 378.08 | 14.91 | 3.60¢ | 38.9 | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Geron explains setback on stem cell study | 28-Aug-2009 | BayArea.com |
| Geron sees progress in stem-cell therapy | 27-Aug-2007 | BayArea.com |
| Stock Ticker | 12-Jun-2007 | BayArea.com |
| Currency | US Dollars |
| Share Price | $ 1.40 |
| Change Today | $ 0.07 |
| % Change | 5.26 % |
| 52 Week High | $3.60 |
| 52 Week Low | $1.07 |
| Volume | 2,579,715 |
| Shares Issued | 186.46m |
| Market Cap | $261.04m |
| RiskGrade | 277 |
| Strong Buy | 2 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 8 |

You are here: research